Page last updated: 2024-11-07

zami 1327

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Zami 1327: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID119519
CHEMBL ID1621422
MeSH IDM0091615

Synonyms (16)

Synonym
2-propanol, 3-(tert-butylamino)-1-(2-nitro-5-methylphenoxy)-, dl-
zami 1327
dl-1-(2-nitro-5-methylphenoxy)-3-tert-butylamino-propan-2-ol
dl-3-(tert-butylamino)-1-(2-nitro-5-methylphenoxy)-2-propanol
OPREA1_421058
1-(tert-butylamino)-3-(5-methyl-2-nitrophenoxy)propan-2-ol
STK018006
86166-57-6
NCGC00246421-01
67971-73-7
2-propanol, 1-((1,1-dimethylethyl)amino)-3-(5-methyl-2-nitrophenoxy)-
1-((1,1-dimethylethyl)amino)-3-(5-methyl-2-nitrophenoxy)-2-propanol
AKOS005378197
CHEMBL1621422
1-(2-nitro-5-methyl-phenoxy) -3-t-butylamino-propan-2-ol
DTXSID90987376

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (14.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]